<?xml version="1.0" ?>
<GlossaryTerm id="CDR0000635737">
  <TermName>BEACOPP regimen</TermName>
  <TermPronunciation>(… REH-jih-men)</TermPronunciation>
  <TermDefinition>
    <DefinitionText>An abbreviation for a chemotherapy combination used to treat advanced Hodgkin lymphoma. It includes the drugs bleomycin sulfate, etoposide phosphate, doxorubicin hydrochloride (Adriamycin), cyclophosphamide, vincristine sulfate (Oncovin), procarbazine hydrochloride, and prednisone. Also called BEACOPP.</DefinitionText>
    <Dictionary>Cancer.gov</Dictionary>
    <Audience>Patient</Audience>
  </TermDefinition>
  <MediaLink ref="CDR0000722845" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;BEACOPP regimen&quot;" language="en" id="_3"/>
  <MediaLink ref="CDR0000722846" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;régimen BEACOPP&quot;" language="es" id="_4"/>
  <SpanishTermName>régimen BEACOPP</SpanishTermName>
  <SpanishTermDefinition>
    <DefinitionText>Nombre de  una quimioterapia combinada que se usa para el tratamiento del linfoma de Hodgkin en estadio avanzado. Incluye los medicamentos sulfato de bleomicina, fosfato de etopósido, clorhidrato de doxorrubicina (Adriamycin), ciclofosfamida,  sulfato de vincristina (Oncovin), clorhidrato de procarbazina y prednisona. También se llama BEACOPP.</DefinitionText>
    <Dictionary>Cancer.gov</Dictionary>
    <Audience>Patient</Audience>
  </SpanishTermDefinition>
  <DateFirstPublished>2009-02-20</DateFirstPublished>
  <DateLastModified>2010-05-05</DateLastModified>
  <RelatedInformation>
    <RelatedDrugSummaryRef UseWith="en" href="CDR0000632570" url="/about-cancer/treatment/drugs/BEACOPP">BEACOPP</RelatedDrugSummaryRef>
  </RelatedInformation>
</GlossaryTerm>
